—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Galenica Sante AG (GALE.SW) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for GALE.SW, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 57/100 · S&P 500 fund at 71, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-10-09
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +5.0% over 20 sessions. Factor regime → 2026-10-12
  • Sector × region Health care in Europe: +1.9% week · +1.9% month · −2.4% quarter · +1.1% yearThe Sector Engine cell this name lives in, from EXV4.XETRA; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-10-11
  • Sovereign pressure Index 0.04 · down 0.71 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-10-09
Who it is priced against Medical Distribution · 4 names with week and year-to-date

Peer group

Medical Distribution

Names in the same industry from the Closelooknet universe; scored names rank on their Closelooknet score, the rest on trend state.

Compared against GALE.SW on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Galenica Sante AG

GALE.SW in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Galenica Sante runs two businesses in Swiss healthcare: retail pharmacies and pharmacy services under brands such as Amavita, Sun Store and Coop Vitality, plus specialty and home-medication services and diagnostic testing; and a logistics and IT arm that stores, distributes and manages data for pharmaceutical and healthcare firms and supplies pharmacies, doctors and care homes. It is headquartered in Bern and was founded in 1927.
Where it sits in the stack
Galenica sits outside our AI build-out index; it belongs to the healthcare and medical-distribution sleeve of our wider universe, covering retail pharmacy and pharmaceutical logistics rather than compute, chips or data-centre infrastructure.
Who it is priced against
Closelooknet has not built a peer group for this name; the comparison the market sometimes draws is with Zur Rose Group, the other large Swiss pharmacy and distribution operator.
Why Closelooknet tracks it
Galenica holds no seat in our indices and carries no Closelooknet score yet; the diary has not quoted it in an edition.
What the diary watches
The diary watches how the balance between the pharmacy-and-care business and the logistics-and-IT business shifts, since the two segments serve different parts of the Swiss healthcare chain.

Galenica Sante AG (GALE.SW) trades on the SW exchange in Switzerland, classified under Healthcare.

The Closelooknet company score reads 44/100 composite (momentum 38, quality 29, valuation 62) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Dividends and capital return trailing yield 2.95%, annual · buybacks 14 m CHF in FY2025

Dividends and capital return

What GALE.SW pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 2.50 CHF per share · a 2.95% yield on the 2026-10-12 close 1 distribution, paid once a year 2026-10-12
  • Change on the year +117.4% against the prior twelve months prior twelve months 1.15 CHF per share
  • Last distribution 2.50 CHF per share as the price series records it, within days of the ex-date 2026-04-23
  • By calendar year 2025: 1.15 CHF (partial) · 2026: 2.50 CHF to date first distribution recorded in the three-year window: 2025-04-14
  • Dividends paid, FY2025 115 m CHF 67% of earnings
  • Buybacks, FY2025 14 m CHF 0.3% of today's market value
  • Share count +0.0% in FY2025 7 m CHF of stock-based compensation in the year
  • Capital returned 129 m CHF · 47% of free cash flow dividends and buybacks together, against the year’s free cash flow

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-10-13

Quick answers

What is Galenica Sante AG (GALE.SW)?

Galenica Sante AG trades as GALE.SW on the SW exchange (Switzerland) and is classified under Healthcare in the Closelooknet research universe, as of the registry build of 2026-10-13.

Is GALE.SW in a Closelooknet index?

Not currently — Galenica Sante AG is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-10-13.

What is Galenica Sante AG's Closelooknet composite score?

44 out of 100, with momentum 38, quality 29 and valuation 62 sub-scores, as of 2026-10-13. Scores are Closelooknet's own research readings, not ratings or investment advice.

Where does GALE.SW trade against its moving averages?

Recovery attempt under the 200-day: Trades +2.5% vs the 50-day and -3.8% vs the 200-day average, 16.6% below the 52-week high and +5.5% off the 52-week low. Computed from daily closes. As of 2026-10-12 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Galenica Sante AG compare with its peers?

Against its peer group (Medical Distribution), Galenica Sante AG (GALE.SW) sits 16.6% below its 52-week high, 2.5% above its 50-day average; McKesson Corporation (MCK) is 4.2% below, Cencora Inc. (COR) is 13.6% below, Cardinal Health Inc (CAH) is 7.8% below. Put any of them next to GALE.SW in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

What does Galenica Sante AG do?

Galenica Sante runs two businesses in Swiss healthcare: retail pharmacies and pharmacy services under brands such as Amavita, Sun Store and Coop Vitality, plus specialty and home-medication services and diagnostic testing; and a logistics and IT arm that stores, distributes and manages data for pharmaceutical and healthcare firms and supplies pharmacies, doctors and care homes. It is headquartered in Bern and was founded in 1927. Closelooknet has not built a peer group for this name; the comparison the market sometimes draws is with Zur Rose Group, the other large Swiss pharmacy and distribution operator.

Where does Galenica Sante AG sit in the AI build-out?

Galenica sits outside our AI build-out index; it belongs to the healthcare and medical-distribution sleeve of our wider universe, covering retail pharmacy and pharmaceutical logistics rather than compute, chips or data-centre infrastructure. Galenica holds no seat in our indices and carries no Closelooknet score yet; the diary has not quoted it in an edition.

Does Galenica Sante AG pay a dividend?

Galenica Sante AG has paid 2.50 CHF per share over the last twelve months, paid once a year, a trailing yield of 2.95% on the 2026-10-12 close; the last distribution recorded in the price series was 2.50 CHF on 2026-04-23. In fiscal 2025 the company paid 115 m CHF in dividends and bought back 14 m CHF of its own shares, 47% of that year’s free cash flow. The share count rose 0.0% over the fiscal year. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for GALE.SW, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Medical Distribution, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.